Health and Welfare Minister Chen Shih-chung (陳時中) said Thursday that the Taiwan government has asked the American drugmaker Gilead Sciences to reserve doses of its experimental drug Remdesivir for potential use in Taiwan, amid reports that the antiviral medication may be effective in treating the novel coronavirus (2019-nCoV).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan to require rooftop solar panels on large new buildings in August
01/22/2026 10:25 PM - Society
New Taipei to probe preschool operator over alleged child abuse cases
01/22/2026 09:25 PM - Society
Cabinet approves draft amendments strengthening counter-terrorism law
01/22/2026 08:30 PM - Business
Unemployment rate drops to 25-year low in 2025
01/22/2026 07:55 PM - Politics